These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 26971196)

  • 1. Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis.
    Six RH; Becskei C; Mazaleski MM; Fourie JJ; Mahabir SP; Myers MR; Slootmans N
    Vet Parasitol; 2016 May; 222():62-6. PubMed ID: 26971196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of sarolaner in the treatment of canine ear mite infestation caused by Otodectes cynotis: a non-inferiority study.
    Becskei C; Cuppens O; Mahabir SP
    Vet Dermatol; 2018 Apr; 29(2):100-e39. PubMed ID: 29392787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.
    Becskei C; De Bock F; Illambas J; Cherni JA; Fourie JJ; Lane M; Mahabir SP; Six RH
    Vet Parasitol; 2016 May; 222():56-61. PubMed ID: 26928658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States.
    Vatta AF; Myers MR; Rugg JJ; Chapin S; Pullins A; King VL; Rugg D
    Vet Parasitol; 2019 Jun; 270 Suppl 1():S3-S11. PubMed ID: 30579753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a new spot-on formulation of selamectin plus sarolaner in the treatment of Otodectes cynotis in cats.
    Becskei C; Reinemeyer C; King VL; Lin D; Myers MR; Vatta AF
    Vet Parasitol; 2017 Apr; 238 Suppl 1():S27-S30. PubMed ID: 28395753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats.
    Taenzler J; de Vos C; Roepke RK; Frénais R; Heckeroth AR
    Parasit Vectors; 2017 Jan; 10(1):30. PubMed ID: 28093080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of lotilaner (Credelio™), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.
    Snyder DE; Wiseman S; Liebenberg JE
    Parasit Vectors; 2017 Nov; 10(1):532. PubMed ID: 29089049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
    Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
    Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis.
    Fourie JJ; Meyer L; Thomas E
    Parasit Vectors; 2019 Jan; 12(1):59. PubMed ID: 30683143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a novel oral formulation of sarolaner (Simparica™) against four common tick species infesting dogs in Europe.
    Geurden T; Becskei C; Grace S; Strube C; Doherty P; Liebenberg J; Mahabir SP; Slootmans N; Lloyd A; Six RH
    Vet Parasitol; 2016 May; 222():33-6. PubMed ID: 27068640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs.
    Six RH; Geurden T; Packianathan R; Colgan S; Everett WR; Grace S; Hodge A; Mahabir SP; Myers MR; Slootmans N; Davis K
    Vet Parasitol; 2016 May; 222():18-22. PubMed ID: 26935820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A European field assessment of the efficacy of fluralaner (Bravecto
    Petersen I; Chiummo R; Zschiesche E; Karas-Tecza J; Rapti D; Roepke R; Thomas E
    Parasit Vectors; 2020 Jun; 13(1):304. PubMed ID: 32527282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation.
    Djuric M; Milcic Matic N; Davitkov D; Glavinic U; Davitkov D; Vejnovic B; Stanimirovic Z
    Parasit Vectors; 2019 May; 12(1):270. PubMed ID: 31138280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a novel oral formulation of sarolaner (Simparica™) against five common tick species infesting dogs in the United States.
    Six RH; Everett WR; Young DR; Carter L; Mahabir SP; Honsberger NA; Myers MR; Holzmer S; Chapin S; Rugg JJ
    Vet Parasitol; 2016 May; 222():28-32. PubMed ID: 26935819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe.
    Becskei C; De Bock F; Illambas J; Mahabir SP; Farkas R; Six RH
    Vet Parasitol; 2016 May; 222():49-55. PubMed ID: 26994516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats.
    Taenzler J; de Vos C; Roepke RKA; Heckeroth AR
    Parasit Vectors; 2018 Nov; 11(1):595. PubMed ID: 30449272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs.
    Carithers D; Crawford J; de Vos C; Lotriet A; Fourie J
    Parasit Vectors; 2016 Dec; 9(1):635. PubMed ID: 27938395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States.
    Cherni JA; Mahabir SP; Six RH
    Vet Parasitol; 2016 May; 222():43-8. PubMed ID: 26947964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs.
    Six RH; Becskei C; Carter L; Gale B; Young DR; Mahabir SP; Chapin S; Myers MR
    Vet Parasitol; 2016 May; 222():23-7. PubMed ID: 26961589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the effective dose of a novel oral formulation of sarolaner (Simparica™) for the treatment and month-long control of fleas and ticks on dogs.
    McTier TL; Six RH; Fourie JJ; Pullins A; Hedges L; Mahabir SP; Myers MR
    Vet Parasitol; 2016 May; 222():12-7. PubMed ID: 26948830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.